Does ALIMTA Cause Malignant neoplasm progression? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Malignant neoplasm progression have been filed in association with ALIMTA. This represents 6.4% of all adverse event reports for ALIMTA.
12
Reports of Malignant neoplasm progression with ALIMTA
6.4%
of all ALIMTA reports
4
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ALIMTA?
Of the 12 reports, 4 (33.3%) resulted in death, 5 (41.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIMTA. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ALIMTA Cause?
Off label use (39)
Anaemia (20)
Thrombocytopenia (20)
Renal failure (16)
Renal failure acute (16)
Pancytopenia (15)
Pyrexia (15)
Diarrhoea (14)
Bone marrow failure (11)
Dyspnoea (11)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ALIMTA Alternatives Have Lower Malignant neoplasm progression Risk?
ALIMTA vs ALIROCUMAB
ALIMTA vs ALISKIREN
ALIMTA vs ALISKIREN HEMIFUMARATE
ALIMTA vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIMTA vs ALIZAPRIDE